Daryl Spinner MBA, PhD

Daryl brings a background spanning R&D, value demonstration, market access and commercialization for a range of health technologies including small molecules and biologicals, regenerative medicines, precision medicine, medical devices, and e-connective technologies. He has experience across multiple therapeutic areas, including oncology, neurology, cardiovascular, respiratory, immunology, metabolic, and genetic and rare diseases. His work has spanned government, industry and consulting sectors, and he has over 60 publications, conference presentations, and abstracts.
Daryl has served on health policy leadership groups related to HTA, HEOR, and market access, including for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Academy of Managed Care Pharmacy (AMCP), National Association of Managed Care Physicians (NAMCP), and other professional associations. He was part of the ISPOR group leadership issuing recommendations on global harmonization of diagnostic HTA processes, the AMCP working group issuing the first guidance to manufacturers on incorporating companion diagnostics evidence into the AMCP Format for Formulary Submissions, and the NAMCP Genomics, Biotech and Emerging Medical Technologies Institute